病毒惰性市场规模、份额和成长分析(按方法、产品、应用、最终用户和地区)- 产业预测 2025-2032
市场调查报告书
商品编码
1630732

病毒惰性市场规模、份额和成长分析(按方法、产品、应用、最终用户和地区)- 产业预测 2025-2032

Viral Inactivation Market Size, Share, Growth Analysis, By Method (Solvent Detergent Method, Pasteurization), By Product (Kits and Reagents, Services), By Application, By End User, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2023 年全球病毒惰性市场规模为6.0237 亿美元,预计将从2024 年的6.7646 亿美元增长到2032 年的17.1112 亿美元,预计在预测期内(2025-2032 年)将达到2032 年的17.1112 亿美元。

受製药、生物技术和医疗保健领域对有效病毒清除的需求不断增加的推动,全球病毒惰性市场预计将大幅扩张。随着生物製药产量的增加,需要采取严格的病毒安全措施来消除生物製药、疫苗和治疗剂中的传染性病原体。遵守 FDA 和 EMA 等组织的监管规定至关重要,推动公司采用强大的技术来降低污染风险。生物製造领域越来越多地采用一次性技术,从而提高了安全性和效率,而这些领域的外包增加则推动了对专门从事研究业务的合约实验室的需求。随着技术的不断进步和对安全的高度重视,市场为创新解决方案和战略伙伴关係关係提供了充足的机会,以确保在公众健康担忧的背景下实现持续增长。

目录

介绍

  • 调查目的
  • 研究范围
  • 定义

调查方法

  • 资讯采购
  • 次要和资料资料
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态及展望

  • 市场概况
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特的分析

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 市场吸引力指数(2024 年)
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析

病毒惰性市场规模(依方法)

  • 市场概况
  • 溶剂清洁剂法
  • 灭菌方法
  • 其他病毒惰性方法

病毒惰性市场规模(依产品划分)

  • 市场概况
  • 套件和试剂
  • 服务
  • 病毒惰性系统及配件

病毒惰性市场规模(依应用)

  • 市场概况
  • 血液和血液製品
  • 细胞和基因疗法产品
  • 干细胞产品
  • 纸巾及纸巾产品
  • 疫苗和治疗

病毒惰性市场规模(依最终用户划分)

  • 市场概况
  • 製药和生物技术公司
  • 合约研究组织
  • 学术研究所
  • 其他最终用户

病毒惰性市场规模

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲国家
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前 5 家公司对比
  • 主要企业市场定位(2024年)
  • 主要市场参与者所采用的策略
  • 近期市场趋势
  • 公司市场占有率分析(2024 年)
  • 主要企业简介
    • 公司简介
    • 产品系列分析
    • 按细分市场分析市场份额
    • 收益与前一年同期比较(2022-2024 年)

主要企业简介

  • Merck KGaA(Germany)
  • Sartorius AG(Germany)
  • Charles River Laboratories International, Inc.(United States)
  • Parker Hannifin Corporation(United States)
  • Thermo Fisher Scientific Inc.(United States)
  • Bio-Rad Laboratories, Inc.(United States)
  • Mettler-Toledo International Inc.(United States)
  • SGS SA(Switzerland)
  • WuXi AppTec Co., Ltd.(China)
  • Lonza Group AG(Switzerland)
  • Pfizer Inc.(United States)
  • GE HealthCare Technologies Inc.(United States)
  • Danaher Corporation(United States)
  • Cerus Corporation(United States)
  • Terumo BCT, Inc.(United States)
  • Eurofins Scientific SE(Luxembourg)
  • Macopharma SA(France)
  • Kedrion SpA(Italy)
  • Rad Source Technologies, Inc.(United States)

结论和建议

简介目录
Product Code: SQMIG35H2143

Global Viral Inactivation Market size was valued at USD 602.37 million in 2023 and is poised to grow from USD 676.46 million in 2024 to USD 1711.12 million by 2032, growing at a CAGR of 12.3% during the forecast period (2025-2032).

The global viral inactivation market is set for significant expansion, driven by a rising demand for effective viral clearance in pharmaceuticals, biotechnology, and healthcare. The increasing production of biopharmaceuticals necessitates stringent viral safety measures to eliminate infectious agents from biological products, vaccines, and therapeutics. Regulatory compliance from organizations like the FDA and EMA is crucial, pushing companies toward robust techniques to reduce contamination risks. The growing adoption of single-use technologies in biomanufacturing enhances safety and efficiency, while the rise in outsourcing within these sectors boosts demand for contract research organizations specializing in viral inactivation services. With ongoing technological advancements and a focus on safety, the market offers ample opportunities for innovative solutions and strategic partnerships, ensuring sustained growth amid public health concerns.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Viral Inactivation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Viral Inactivation Market Segmental Analysis

Global Viral Inactivation Market is segmented by Method, Product, Application, End User and region. Based on Method, the market is segmented into Solvent Detergent Method, Pasteurization and Other Viral Inactivation Method. Based on Product, the market is segmented into Kits and Reagents, Services and Viral Inactivation Systems and Accessories. Based on Application, the market is segmented into Blood & Blood Products, Cellular & Gene Therapy Products, Stem Cell Products, Tissue & Tissue Products and Vaccines and Therapeutics. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Research Institutes and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Viral Inactivation Market

The Global Viral Inactivation market is significantly influenced by advancements in the biopharmaceutical sector, particularly in the development of monoclonal antibodies, gene therapies, and personalized medicine. As the production of intricate biologics and innovative therapies expands, the necessity for reliable viral inactivation techniques intensifies in order to safeguard the integrity and safety of these treatments. This growing demand is further fueled by stringent regulatory requirements and a heightened focus on delivering high-quality, contaminant-free biopharmaceutical products. Consequently, the pursuit of effective viral inactivation solutions is essential to address these challenges and ensure the safe development of cutting-edge medical advancements.

Restraints in the Global Viral Inactivation Market

The viral inactivation market faces significant restraints due to the complex regulatory environment that governs the pharmaceutical and biotechnology industries. The stringent and constantly changing requirements established by regulatory bodies like the FDA and EMA complicate the navigation for businesses in this field. Companies are often required to conduct extensive validation studies and maintain rigorous documentation to prove the efficacy of their viral inactivation techniques, which can be both time-intensive and costly. This intricate regulatory landscape can hinder market growth and innovation by placing additional burdens on companies as they strive to meet compliance standards.

Market Trends of the Global Viral Inactivation Market

The Global Viral Inactivation market is experiencing a robust upward trend, propelled by the surge in biopharmaceutical manufacturing, particularly with the rise of monoclonal antibodies, gene therapies, and cell-based therapies. As these innovative biologics become essential for tailored therapeutic approaches, there is an increasing imperative for enhanced viral safety protocols to mitigate contamination risks. This demand is catalyzing the adoption of advanced viral inactivation techniques, reflecting a broader industry transition towards cutting-edge treatment modalities and the integration of sophisticated technologies. Consequently, this trend is significantly contributing to the market's expansion, signaling a pivotal evolution in biopharmaceutical safety standards and practices.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Viral Inactivation Market Size by Method & CAGR (2025-2032)

  • Market Overview
  • Solvent Detergent Method
  • Pasteurization
  • Other Viral Inactivation Method

Global Viral Inactivation Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Kits and Reagents
  • Services
  • Viral Inactivation Systems and Accessories

Global Viral Inactivation Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Blood & Blood Products
  • Cellular & Gene Therapy Products
  • Stem Cell Products
  • Tissue & Tissue Products
  • Vaccines and Therapeutics

Global Viral Inactivation Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Academic Research Institutes
  • Other End Users

Global Viral Inactivation Market Size & CAGR (2025-2032)

  • North America (Method, Product, Application, End User)
    • US
    • Canada
  • Europe (Method, Product, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Method, Product, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Method, Product, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Method, Product, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Charles River Laboratories International, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Parker Hannifin Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mettler-Toledo International Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SGS SA (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • WuXi AppTec Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza Group AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE HealthCare Technologies Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cerus Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo BCT, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific SE (Luxembourg)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Macopharma SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kedrion S.p.A. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rad Source Technologies, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations